COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01067521
Brief Title: A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo (GALA)

First Submitted : February 10, 2010
First Submitted that Met QC Criteria : February 10, 2010
First Posted : February 11, 2010 (Estimate)

Results First Submitted : July 17, 2018
Results First Submitted that Met QC Criteria : September 11, 2018
Results First Posted : October 9, 2018

Last Update Submitted that Met QC Criteria : October 21, 2018
Last Update Posted : November 14, 2018